USPTO serial 97977637
STANDARD BIOTOOLS
Reviewed by CopyMark Law Group
Status 774
- Filing date
- Status date
- Registration date
- —
- Examiner
- SWAIN, MICHELE LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with STANDARD BIOTOOLS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA
South San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
R. GWEN PETERSON
R. GWEN PETERSON KILPATRICK TOWNSEND & STOCKTON LLP2175 NORTH CALIFORNIA BLVD, SUITE 600WALNUT CREEK, CA 94596UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays and reagents for use in genetic research and research in the field of cell detection, cell characterization, biochemical and chemical analysis, biological function testing, genotyping, and biomolecule sequencing; biochemical reagents commonly known as probes for non-medical purposes for detecting and analyzing molecules in protein or nucleotide arrays; electrodiagnostic preparations for scientific or research use; reagents for chemical analyses other than for medical or veterinary purposes; reagents for scientific or medical research use; reagents for use in scientific apparatus for chemical or biological analysis; diagnostic reagents other than for medical or veterinary purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry, microbiology, and genotyping, other than for medical or veterinary purposes. | ACTIVE | — |
| 005 | Nucleic medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences and chemical reagents for medical and veterinary purposes | ACTIVE | — |
| 009 | Laboratory equipment, namely, cytometers used to measure chemical and physical characteristics of cells and biomolecules and downloadable software for the operation of and analysis of the data from same; microfluidic instrumentation for use in analytical chemistry and other scientific fields where molecular or cell separation is desirable or movement of gases or liquids on a microscale is needed, and downloadable software for the operation of and analysis of the data from same and downloadable software for biochip design embodying same; mass spectrometric instrumentation, namely, flow cytometers used to measure chemical and physical characteristics of cells and other particles by means of biospectrometry and optical detection and downloadable software for the operation of and analysis of the data from same and downloadable software for assay and workflow design for same; laboratory instruments and devices used for genetic research, namely, microfluidic flow controls; laboratory microfluidic instruments and devices, namely, microfluidic flow controls for use in genetic research where molecular or cell separation is desirable or movement of gases or liquids on a microscale is needed; laboratory instruments, namely, mass spectrometric instrumentation for genetic research, namely, flow cytometers by means of biospectrometry and optical detection where it is desirable to measure chemical and physical characteristics of cells and other particles | ACTIVE | — |
| 010 | Instruments and devices for use in medical diagnostic research, namely, microfluidic flow controls; microfluidic instruments and devices, namely, microfluidic flow controls for use in medical diagnostic research and for other medical uses where molecular or cell separation is desirable or movement of gases or liquids on a microscale is needed; biochips for medical purposes which employ microfluidic pumps and valves; mass spectrometric instrumentation for medical purposes for use in medical diagnostic research and for medical uses, namely, flow cytometers by means of mass-spectrometry and optical detection where it is desirable to measure chemical and physical characteristics of cells and other particles | ACTIVE | — |
| 040 | Custom fabrication of antibody conjugate reagents; custom fabrication of microfluidic flow controls and biochips employing microfluidic technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Standard BioTools Inc.
- Other trademarks owned by Standard BioTools Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 040
- Similar marks named STANDARD BIOTOOLS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2025 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jun 2, 2025 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Dec 23, 2024 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 9, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 18, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 18, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 18, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 18, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 12, 2024 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Aug 12, 2024 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Aug 12, 2024 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Jun 18, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 17, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 17, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 7, 2024 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 8, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Feb 8, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Feb 5, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 13, 2023 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Dec 13, 2023 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Nov 24, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 24, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 24, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 14, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 12, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 13, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 14, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 14, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 15, 2022 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Nov 15, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 15, 2022 | ALIE | ASSIGNED TO LIE | — |
| Sep 28, 2022 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Sep 26, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 26, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 26, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2022 | NWAP | NEW APPLICATION ENTERED | — |